Tag Archives: treatment

Farletuzumab Trial Fails to Show Increase in PFS

A Phase III trial of a potential new treatment for ovarian cancer, farletuzumab, did not know any improvement in progression free survival. See a new article here

Posted in News | Also tagged , , | Leave a comment

EU Reviews Folate Receptor Drug

The European Union will review vintafolide, a folate receptor drug for ovarian cancer, made by Endocyte/Merck. The regulatory agency should make a decision in the first half of 2013. Read … Continue reading 

Posted in News | Also tagged | Leave a comment

Physiological Evidence of “Cancer Brain” Found

Using PET/CT scans, researchers looked at the brain function of 128 breast cancer patients. The study aimed to show that PET/CT is a useful tool to measure the presence of … Continue reading 

Posted in News | Also tagged , | Leave a comment

EU Approves Avastin in Combination Therapy for Recurrent Ovarian Cancer

The European Commission approved the use of Avastin with Gemzar and Carboplatin for treatment of the first recurrence of ovarian cancer. See the article here

Posted in News | Also tagged , , , | Leave a comment

Researchers Uncover New Mechanism of Action for PARP Inhibitors

It appears that molecules currently classified as PARP inhibitors may work in one, or both, ways. One mechanism of action inhibits PARP enzyme activity; the other acts as a “PARP … Continue reading 

Posted in News | Also tagged , | Leave a comment

Fertility Sparing Surgery Recommended by Study

A study of 240 patients with ovarian cancer concluded that young women with early stage disease be provided the option of fertility sparing surgery, rather than aggressive debulking. The study … Continue reading 

Posted in News | Also tagged , , , , , | Leave a comment

Taxane Therapy Does Not Affect Pregnancy

A small retrospective study of women receiving taxane therapy for breast or ovarian cancer while pregnancy showed no statistically significant outcomes in maternal or fetal health. Read the abstract here

Posted in News | Also tagged , , , , | Leave a comment

When Less Is More – Editorial

The L.A. Times published an editorial July 29 summing up years of data showing that aggressively screening and treating people for cancer does not always benefit them. The editorial also … Continue reading 

Posted in News | Also tagged , , , , , , , , , , | Leave a comment

Fasting Before Chemotherapy?

There is a growing body of data indicating that fasting before chemotherapy renders cancer cells more sensitive to the toxic effects of those drugs. On the other side of the … Continue reading 

Posted in News | Also tagged , , , , , , , , | Leave a comment

Drugs Approved Faster in US, Cost More

According to a study by the Tufts Center for the Study of Drug Development, more cancer drugs were approved in the US than in the EU during the 2010-2011 time … Continue reading 

Posted in News | Also tagged , , , , , , , , | Leave a comment

New Study on BRCA Mutation in Women with Ovarian Cancer

A new study of 1,001 women with ovarian cancer found that 14% of them carried a BRCA1 or BRCA2 mutation. However, 44% of those women did not have a family … Continue reading 

Posted in News | Also tagged , , , , , , , | Leave a comment

Drug Costs an Issue in Cancer Care

The costs of drugs is increasingly becoming an issue in cancer care. The balance of quality and cost raises the issue of cost effectiveness. More presentations at the recent ASCO … Continue reading 

Posted in News | Also tagged , , , | Leave a comment